Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Global Payout, Inc. (GOHE) Offers Transnational Finance Tech Solutions in Expanding Marketplace

2018 is expected to bring further fintech growth worldwide Global Payout services empower global industries through chain finance solutions Global Reserve Platform and new subsidiary will target logistics and shipping payment needs As fintech industries enter the new year, corporate entities building blockchain capacity such as Global Payout, Inc. (OTC: GOHE) are looking for blue […]

Net Element, Inc. (NASDAQ: NETE) Receives $2.7 Million from Sale of Common Shares

NETE received $2,683,835 from sales of common stock in multiple transactions with Cobblestone Capital Partners, LLC Proceeds are expected to be used for working capital and general corporate purposes NETE recently launched new blockchain-based business unit to provide value-added services and transaction support in the cryptocurrency market Net Element, Inc. (NASDAQ: NETE) has received $2.7 […]

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Marks Milestone with Patent Approval

LXRP awarded broad-ranging U.S. patent for novel DehydraTECH™ drug delivery system Already scientifically proven to increase efficacy of cannabinoids IP protection opens myriad business opportunities Food bioscience company Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) just hit another major milestone in the disruption of drug delivery and administration. With 19 international patent applications filed encompassing […]

DOJA Cannabis Company Ltd. (CSE: DOJA) (OTC: DJACF) is “One to Watch”

Premium cannabis lifestyle brand founded by team that started SAXX Underwear® One of only 26 Health Canada licensed cannabis production facilities Canada’s recreational marijuana market estimated at up to $8.7 billion Initial cannabis harvests are complete; awaiting Health Canada pre-sales inspection DOJA Cannabis Company Ltd. (CSE: DOJA) (OTC: DJACF) is a premium cannabis lifestyle brand […]

Skinvisible, Inc. (SKVI) Partnership with Quoin Focuses on Population’s Pain Needs

Non-binding proposed merger announced on November 27, 2017 Quoin merger expected to deliver non-opioid relief to post-surgical patients Over-65 population with advanced pain needs expected to double within next 30 years Skinvisible and Quoin proposed merger expected to deliver better results to patients Health professionals are preparing for an expected doubling of the 65 years […]

Net Element, Inc. (NASDAQ: NETE) Delivers Financial Technology Solutions for Today’s Retailers and Consumers

Net Element mobile payment solutions and services unite the retailer, consumer and market with advanced technology The company is keeping up with financial technology (FinTech) trends that are disrupting retail banking in a booming market, with U.S. e-commerce sales projected to surpass $360.3 billion in 2021 Net Element solutions enable mobile payment options, chat-bots, and […]

Petrogress, Inc. (PGAS) is Strengthening Port Operations in Cyprus

MOU to undertake joint venture in Cyprus port operations Set to enter upstream business by operating oil platform Gaining eligibility to bid for Ghanaian government contracts A recent announcement (http://dtn.fm/GtI6w), which also appeared in the Greek media, shows that Petrogress, Inc. (OTC: PGAS) is doubling down in Cyprus. Through subsidiary Petrogress Int’l, LLC (“PIL”), the […]

 

From Our Blog

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Has the World’s Only Clinical-Stage PP2A Inhibitor, Poised to Improve Cancer Treatment Outcomes

March 31, 2026

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company, is in the unique position of holding the world’s only clinical-stage protein phosphatase 2A (“PP2A”) inhibitor, called LB-100. The LB-100 compound is a proprietary small-molecule PP2A inhibitor that is designed to target protein phosphatase 2A (“PP2A”), introducing a potential new treatment paradigm aimed at enhancing existing […]

Rotate your device 90° to view site.